Promotions & Moves

Lonza CEO Steps Down

Albert Baehny, chairman, will take on the responsibility on an interim basis.

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza’s chief executive officer, Marc Funk, will leave the Company for personal reasons. Albert Baehny, chairman, will take on the additional responsibility of chief executive officer on an interim basis until a permanent successor is named. Marc will remain with the company until January 2020 to ensure a smooth transition. Also, board member Christoph Maeder has been appointed Lead Independent Director by the Board.

Christoph Maeder, Lead Independent Director said, “Albert has agreed to lead the Company on a temporary basis until a successor is in place, for which a search has commenced. The Board respects Marc’s decision and would like to thank him for his service to Lonza and wish him well for his future endeavors.”
 
Albert Baehny, Chairman said, “I am committed to Lonza, its employees and all its stakeholders and I will ensure that I work in their best interests in the months ahead. The Company has an exciting future in dynamic markets and I am keen to ensure that we maintain our momentum and capture all the opportunities available to us. I look forward to working with colleagues, customers, partners and other stakeholders in the coming months and also to working with the Board in the search for a new Chief Executive Officer to lead the Company in the years ahead.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters